The Spillover Effect of the Medicare Mandatory Bundled Payment Program on Joint Replacement Outcomes: Analysis of Patients with Commercial Insurance and Medicare Advantage.
Journal
The Journal of bone and joint surgery. American volume
ISSN: 1535-1386
Titre abrégé: J Bone Joint Surg Am
Pays: United States
ID NLM: 0014030
Informations de publication
Date de publication:
06 Apr 2022
06 Apr 2022
Historique:
medline:
14
12
2021
pubmed:
14
12
2021
entrez:
13
12
2021
Statut:
ppublish
Résumé
To improve the value and efficiency of care among traditional Medicare enrollees, the Centers for Medicare & Medicaid Services has implemented alternative payment models designed to control health-care spending and improve quality. These models may affect care beyond traditional Medicare enrollees, "spilling over" into other populations. Established in April 2016, the Medicare mandatory bundled payment program, called the Comprehensive Care for Joint Replacement (CJR) model, holds hospitals accountable for spending and quality of care for traditional Medicare joint-replacement patients during care episodes that span from the index hospitalization to 90 days post-discharge. We assessed the extent to which the CJR model was associated with outcomes for patients enrolled in commercial insurance and Medicare Advantage plans. With use of Health Care Cost Institute claims data from 2012 through 2017, we assessed the association of the CJR model with total expenditures, discharges to institutional post-acute care, and readmissions among commercial insurance and Medicare Advantage joint-replacement patients. The exposure variable was the implementation of the CJR model in 67 randomly selected metropolitan statistical areas compared with 103 similar areas without CJR implementation. We utilized difference-in-differences models to estimate the spillover effects of the CJR model by comparing outcomes between these areas before and after CJR implementation. The study included 174,893 joint-replacement episodes of care in commercial insurance enrollees and 202,070 episodes in Medicare Advantage enrollees. Among both commercial insurance and Medicare Advantage enrollees, CJR implementation was associated with no meaningful changes in total episode expenditures, discharges to institutional post-acute care, or readmissions. We found no evidence for spillover effects of the CJR model on commercial insurance and Medicare Advantage patients, suggesting that alternative payment models targeting traditional Medicare patients may have limited effects on the cost and quality of care for patients outside of the traditional Medicare system.
Sections du résumé
BACKGROUND
BACKGROUND
To improve the value and efficiency of care among traditional Medicare enrollees, the Centers for Medicare & Medicaid Services has implemented alternative payment models designed to control health-care spending and improve quality. These models may affect care beyond traditional Medicare enrollees, "spilling over" into other populations. Established in April 2016, the Medicare mandatory bundled payment program, called the Comprehensive Care for Joint Replacement (CJR) model, holds hospitals accountable for spending and quality of care for traditional Medicare joint-replacement patients during care episodes that span from the index hospitalization to 90 days post-discharge. We assessed the extent to which the CJR model was associated with outcomes for patients enrolled in commercial insurance and Medicare Advantage plans.
METHODS
METHODS
With use of Health Care Cost Institute claims data from 2012 through 2017, we assessed the association of the CJR model with total expenditures, discharges to institutional post-acute care, and readmissions among commercial insurance and Medicare Advantage joint-replacement patients. The exposure variable was the implementation of the CJR model in 67 randomly selected metropolitan statistical areas compared with 103 similar areas without CJR implementation. We utilized difference-in-differences models to estimate the spillover effects of the CJR model by comparing outcomes between these areas before and after CJR implementation.
RESULTS
RESULTS
The study included 174,893 joint-replacement episodes of care in commercial insurance enrollees and 202,070 episodes in Medicare Advantage enrollees. Among both commercial insurance and Medicare Advantage enrollees, CJR implementation was associated with no meaningful changes in total episode expenditures, discharges to institutional post-acute care, or readmissions.
CONCLUSIONS
CONCLUSIONS
We found no evidence for spillover effects of the CJR model on commercial insurance and Medicare Advantage patients, suggesting that alternative payment models targeting traditional Medicare patients may have limited effects on the cost and quality of care for patients outside of the traditional Medicare system.
Identifiants
pubmed: 34898513
doi: 10.2106/JBJS.21.00259
pii: 00004623-990000000-00412
pmc: PMC9189235
mid: NIHMS1763624
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
621-629Subventions
Organisme : AHRQ HHS
ID : R01 HS026457
Pays : United States
Informations de copyright
Copyright © 2021 by The Journal of Bone and Joint Surgery, Incorporated.
Déclaration de conflit d'intérêts
Disclosure: The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article ( http://links.lww.com/JBJS/G825 ).
Références
J Gen Intern Med. 2018 Jun;33(6):831-838
pubmed: 29520748
JAMA. 2018 Sep 4;320(9):892-900
pubmed: 30193277
J Health Econ. 2002 Mar;21(2):337-53
pubmed: 11939245
Arthroplast Today. 2018 Mar 21;4(2):221-226
pubmed: 29896557
Ann Intern Med. 2021 Feb;174(2):200-208
pubmed: 33347769
JAMA Netw Open. 2020 Sep 1;3(9):e2014475
pubmed: 32960277
Med Care. 2020 May;58(5):491-495
pubmed: 31914103
J Bone Joint Surg Am. 2010 Nov 17;92(16):2643-52
pubmed: 21084575
Annu Rev Public Health. 2003;24:435-56
pubmed: 12471276
JAMA. 2020 Nov 17;324(19):1998
pubmed: 33201200
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):18939-18947
pubmed: 32719129
N Engl J Med. 2019 Jan 17;380(3):252-262
pubmed: 30601709
J Arthroplasty. 2017 Feb;32(2):367-374
pubmed: 27600304
JAMA Netw Open. 2019 Nov 1;2(11):e1914696
pubmed: 31693127
JAMA Netw Open. 2019 Dec 2;2(12):e1918535
pubmed: 31880803
J Arthroplasty. 1999 Feb;14(2):182-6
pubmed: 10065724
JAMA. 2013 Aug 28;310(8):829-36
pubmed: 23982369
Healthc (Amst). 2020 Dec;8(4):100447
pubmed: 33129181
JAMA Surg. 2020 Jan 1;155(1):82-84
pubmed: 31577346
Health Serv Res. 2014 Oct;49(5):1578-95
pubmed: 24850524
JAMA Intern Med. 2019 Jul 1;179(7):924-931
pubmed: 31157819